Telisotuzumab vedotin (Teliso-V) monotherapy in patients (pts) with previously treated c-Met-overexpressing (OE) advanced non-small cell lung cancer (NSCLC).

---

Camidge D. R., Bar J., Horinouchi H., Goldman J. W., Moiseenko F. V., Filippova E., ...More

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 3 - 07 June 2022, vol.40, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• Volume: 40
• Country: ELECTR NETWORK
• Trakya University Affiliated: Yes